580 related articles for article (PubMed ID: 32661321)
1. Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.
Gracey E; Vereecke L; McGovern D; Fröhling M; Schett G; Danese S; De Vos M; Van den Bosch F; Elewaut D
Nat Rev Rheumatol; 2020 Aug; 16(8):415-433. PubMed ID: 32661321
[TBL] [Abstract][Full Text] [Related]
2. The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.
Qaiyum Z; Lim M; Inman RD
Semin Immunopathol; 2021 Apr; 43(2):173-192. PubMed ID: 33625549
[TBL] [Abstract][Full Text] [Related]
3. Gut inflammation and microbiome in spondyloarthritis.
Kabeerdoss J; Sandhya P; Danda D
Rheumatol Int; 2016 Apr; 36(4):457-68. PubMed ID: 26719306
[TBL] [Abstract][Full Text] [Related]
4. The ties that bind: skin, gut and spondyloarthritis.
Gracey E; Dumas E; Yerushalmi M; Qaiyum Z; Inman RD; Elewaut D
Curr Opin Rheumatol; 2019 Jan; 31(1):62-69. PubMed ID: 30407224
[TBL] [Abstract][Full Text] [Related]
5. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis.
Lyu X; Chen J; Gao X; Yang J
Front Cell Infect Microbiol; 2022; 12():973563. PubMed ID: 36072223
[TBL] [Abstract][Full Text] [Related]
6. Fecal transplants in spondyloarthritis and uveitis: ready for a clinical trial?
Choi RY; Asquith M; Rosenbaum JT
Curr Opin Rheumatol; 2018 Jul; 30(4):303-309. PubMed ID: 29538010
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician.
Lubrano E; Luchetti MM; Benfaremo D; Mauro D; Ciccia F; Perrotta FM
Expert Rev Clin Immunol; 2021 Nov; 17(11):1199-1209. PubMed ID: 34622735
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practice.
Cypers H; Van Praet L; Varkas G; Elewaut D
Curr Opin Rheumatol; 2014 Jul; 26(4):371-6. PubMed ID: 24841232
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
Faustini F; Zoli A; Ferraccioli GF
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
[TBL] [Abstract][Full Text] [Related]
10. Integrating the pathogenesis of spondyloarthritis: gut and joint united?
De Wilde K; Debusschere K; Beeckman S; Jacques P; Elewaut D
Curr Opin Rheumatol; 2015 Mar; 27(2):189-96. PubMed ID: 25588139
[TBL] [Abstract][Full Text] [Related]
11. Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis.
Luchetti MM; Ciccia F; Avellini C; Benfaremo D; Rizzo A; Spadoni T; Svegliati S; Marzioni D; Santinelli A; Costantini A; Viola N; Berretta A; Ciferri M; Mattioli Belmonte Cima M; Mosca P; Benedetti A; Gabrielli A
Rheumatology (Oxford); 2021 Jan; 60(1):92-102. PubMed ID: 32442267
[TBL] [Abstract][Full Text] [Related]
12. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
Wang CR; Tsai HW
World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
[TBL] [Abstract][Full Text] [Related]
13. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
14. Joint involvement associated with inflammatory bowel disease.
De Vos M
Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
[TBL] [Abstract][Full Text] [Related]
15. Occult spondyloarthritis in inflammatory bowel disease.
Bandinelli F; Manetti M; Ibba-Manneschi L
Clin Rheumatol; 2016 Feb; 35(2):281-9. PubMed ID: 26354428
[TBL] [Abstract][Full Text] [Related]
16. Osteoarticular manifestations: specific treatments and/or treating intestinal disease?
De Vos M; Van Praet L; Elewaut D
Dig Dis; 2013; 31(2):239-43. PubMed ID: 24030233
[TBL] [Abstract][Full Text] [Related]
17. [Update: enterogenic spondylarthritis].
Märker-Hermann E
Z Rheumatol; 2021 Aug; 80(6):539-551. PubMed ID: 34046687
[TBL] [Abstract][Full Text] [Related]
18. The intestinal microbiome in spondyloarthritis.
Gill T; Asquith M; Rosenbaum JT; Colbert RA
Curr Opin Rheumatol; 2015 Jul; 27(4):319-25. PubMed ID: 26002022
[TBL] [Abstract][Full Text] [Related]
19. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
Mielants H; Veys EM
Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
[TBL] [Abstract][Full Text] [Related]
20. Spondyloarthritis and inflammatory bowel disease. Comorbidity and treatment implications.
Varkas G; Van Praet L; Cypers H; Elewaut D
Z Rheumatol; 2013 Aug; 72(6):524-9. PubMed ID: 23756592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
